That’s according to a clinical trial conducted in 11 countries — the first of its kind to show that one of the wave of ...

A new study reveals that among privately insured patients with obesity, weight loss drug use has more than doubled and ...

2024 — A new study has examined a large sample of privately insured patients with obesity and found that use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as anti-obesity medications ...

Nutrition Changes: There are several nutrition strategies that can help improve insulin resistance. For healthy blood sugar ...

It’s Election Day, and we want to hear from you ... pointing to America’s lagging life expectancy, and high rates of cancer, ...

Popular weight-loss drug Wegovy maker Novo Nordisk expects high demand and acceptance for its anti-obesity drug, when ...

The updated AAP clinical guidelines on obesity treatment recommend offering the full spectrum of care upon initial obesity ...

As the battle against obesity and diabetes heats up, two new superstars are entering the ring in Spain - Mounjaro (also known ...

CRB-913 brain levels are 15-fold lower than monlunabant in lean miceDose-response demonstrated for a range of 5 to 80 mg/kg/day achieving up to ...

We include anti-inflammatory ingredients such as salmon ... the risk of developing type 2 diabetes and the progression of obesity-linked insulin resistance. Reducing chronic inflammation can ...